Toronto and Vancouver, Canada: Zucara Therapeutics Inc., a diabetes life sciences company advancing the first once-daily therapeutic to prevent low blood
VANCOUVER and TORONTO, Canada — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to
Michael Midmer, CEO of Zucara Therapeutics, is confirmed to present at the 10th Annual Biotech Showcase. This important investor and
NEW YORK, USA and TORONTO, Canada, September 21, 2017 — As Global Biotech Week begins in more than 20 countries,
VANCOUVER and TORONTO, Canada — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to
VANCOUVER and TORONTO, Canada (July 10, 2017) — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term
On March 3, 2017 Rocket Builders announced its 15th annual “Ready to Rocket” lists. These lists profile British Columbia technology companies that
New paper published in The Lancet Diabetes & Endocrinology recommends exercise guidelines for type 1 diabetes patients and healthcare providers.
For Immediate Release BC Ministry of Health Diabetes Awareness Month: diabetes research VICTORIA – Health Minister Terry Lake has issued the
Zucara announced it has received a $525,000 investment from Canadian partners: Accel-Rx Health Sciences Accelerator, The Centre for Drug Research